MBChB Auckland, FRCSEd, MMedSci Keele, MLitt St. And.
I graduated in medicine from the University of Auckland, then worked for several years as a doctor, specialising in colorectal surgery. I took a career break and worked as a statistician in London for a few years before returning to a medical career in Oxford in 2013.
I am currently in my first year of a DPhil looking at prognostic factors in early rectal cancer and the implications for rectal preservation surgery. Rectal cancer affects 11,000 people per year in the UK; early rectal cancer is increasingly common due to screening programmes. Minimally-invasive surgery which preserves the rectum is much better tolerated by patients than conventional radical surgery. However, it risks leaving involved lymph nodes which may later cause recurrence. In order to fully inform patients about the risks and implications of different surgical options and the most appropriate adjuvant treatments, it is important to have as much information as possible, as early as possible after diagnosis, about each specific patient’s tumour, so that treatment can be personalised.
Modern management of T1 rectal cancer by TEM:a ten-year single-centre experience.
Jones HJS. et al, (2018), Colorectal Dis
Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
Jones HJS. et al, (2018), Eur J Surg Oncol, 44, 15 - 23
The LOREC APE registry: operative technique, oncological outcome and perineal wound healing after abdominoperineal excision.
Jones H. et al, (2017), Colorectal Dis, 19, 172 - 180
Is group pelvic floor retraining as effective as individual treatment?
Jones HJS. et al, (2015), Colorectal Dis, 17, 515 - 521